NICE approves multiple sclerosis drugs after prices are reduced

NICE approves multiple sclerosis drugs after prices are reduced

Reductions to the price of three multiple sclerosis (MS) drugs mean NICE is now able to recommend them for routine NHS funding.

Read article

New guidance will help combat drug resistant urinary tract infections, says NICE

New guidance will help combat drug resistant urinary tract infections, says NICE

NICE has published new guidance to help healthcare professionals optimise the treatment of urinary tract infections (UTIs).

Read article

Hundreds of people with blood cancer given more treatment options after NICE recommends three drugs

Hundreds of people with blood cancer given more treatment options after NICE recommends three drugs

NICE has recommended three blood cancer drugs, brentuximab vedotin, midostaurin and arsenic trioxide be made available on the NHS.

Read article

Long term benefit of neuroblastoma treatment is too uncertain, says NICE

Long term benefit of neuroblastoma treatment is too uncertain, says NICE

NICE has published draft guidance in which dinutuximab beta is not recommended as a treatment for high-risk neuroblastoma – a rare type of cancer that mainly affects children and young people.

Read article

Latest news headlines